PB2209: HIGH RISK MYELODYSPLASTIC SYNDROME DEVELOPING IN A PATIENT AFTER CHIMERIC ANTIGEN RECEPTOR (CAR) T- CELL THERAPY FOR RELAPSED DIFFUSE LARGE B CELL LYMPHOMA

Detalles Bibliográficos
Autores principales: Accorsi Buttini, E., Farina, M., Turra, A., Morello, E., Polverelli, N., Colnaghi, F., Almici, C., Ferrari, E., Bianchetti, A., Leoni, A., Re, F., Bosio, K., Bernardi, S., Malagola, M., Re, A., Russo, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431380/
http://dx.doi.org/10.1097/01.HS9.0000851664.86963.2d

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431380/
http://dx.doi.org/10.1097/01.HS9.0000851664.86963.2d

Ejemplares similares